Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
European Journal of Gastroenterology & Hepatology
|
September 5, 2022
Risk factors for decompensation and death following umbilical hernia repair in patients with end-stage liver disease
Abdullah K Malik, Chris Varghese, Sanjay Pandanaboyana, et al.
Journal of Clinical and Experimental Hepatology
|
October 11, 2018
A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis
Gautam Mehta, Sam Rousell, Gary Burgess, et al.
The Lancet. Gastroenterology & Hepatology
|
May 7, 2022
Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic review
Kushala W M Abeysekera, Iain Macpherson, Kate Glyn-Owen, et al.
Journal of Viral Hepatitis
|
October 14, 2018
Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine
Sarah Morey, Abi Hamoodi, Dee Jones, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
February 7, 2025
Visual assessment of liver steatosis at retrieval predicts long term liver transplant outcomes in donation following circulatory death
Ning X Ho, Samuel J Tingle, Georgios Kourounis, et al.
Journal of Hepatology
|
May 2, 2016
Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
Laura F Ogle, James G Orr, Catherine E Willoughby, et al.
Advances in Therapy
|
October 25, 2019
Efficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter Study
Robert J Fontana, Sabela Lens, Stuart McPherson, et al.
Frontline Gastroenterology
|
October 26, 2017
Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey
David A Sheridan, Guru Aithal, William Alazawi, et al.
Gut
|
March 23, 2016
Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
Timothy Hardy, Mujdat Zeybel, Christopher P Day, et al.
Journal of Hepatology
|
June 10, 2009
Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered
Stuart McPherson, Julie R Jonsson, Gary J Cowin, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
European Journal of Gastroenterology & Hepatology
|
September 5, 2022
Risk factors for decompensation and death following umbilical hernia repair in patients with end-stage liver disease
Abdullah K Malik, Chris Varghese, Sanjay Pandanaboyana, et al.
Journal of Clinical and Experimental Hepatology
|
October 11, 2018
A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis
Gautam Mehta, Sam Rousell, Gary Burgess, et al.
The Lancet. Gastroenterology & Hepatology
|
May 7, 2022
Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic review
Kushala W M Abeysekera, Iain Macpherson, Kate Glyn-Owen, et al.
Journal of Viral Hepatitis
|
October 14, 2018
Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine
Sarah Morey, Abi Hamoodi, Dee Jones, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
February 7, 2025
Visual assessment of liver steatosis at retrieval predicts long term liver transplant outcomes in donation following circulatory death
Ning X Ho, Samuel J Tingle, Georgios Kourounis, et al.
Journal of Hepatology
|
May 2, 2016
Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
Laura F Ogle, James G Orr, Catherine E Willoughby, et al.
Advances in Therapy
|
October 25, 2019
Efficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter Study
Robert J Fontana, Sabela Lens, Stuart McPherson, et al.
Frontline Gastroenterology
|
October 26, 2017
Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey
David A Sheridan, Guru Aithal, William Alazawi, et al.
Gut
|
March 23, 2016
Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
Timothy Hardy, Mujdat Zeybel, Christopher P Day, et al.
Journal of Hepatology
|
June 10, 2009
Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered
Stuart McPherson, Julie R Jonsson, Gary J Cowin, et al.
Page
of 11